Alphacentric Lifesci Healthcare Fund Investor Sentiment

LYFAX Fund  USD 13.31  0.09  0.67%   
Slightly above 62% of Alphacentric Lifesci's investor base is looking to short. The analysis of overall sentiment of trading Alphacentric Lifesci Healthcare mutual fund suggests that many investors are alarmed at this time. Alphacentric Lifesci's investing sentiment can be driven by a variety of factors including economic data, Alphacentric Lifesci's earnings reports, geopolitical events, and overall market trends.
  
over six months ago at news.google.com         
Form N-CSRS MUTUAL FUND SERIES TRUST For Sep 30 - StreetInsider.com
Google News at Macroaxis
over a year ago at news.google.com         
Federal Home Loan Bank of Dallas Provides 1 million for Arkansas and Mississippi Storm Recovery - Ya...
Google News at Macroaxis
a day ago at bnnbloomberg.ca         
Marburgs Global Risk Almost Eliminated by Rwandas Quick Response
bloomberg News
3 days ago at finance.yahoo.com         
Gilead Sciences Increases Yet Falls Behind Market What Investors Need to Know
Yahoo News
few days ago at statnews.com         
The biotech news stories you need to read this morning
news
few days ago at finance.yahoo.com         
The SP 500 will jump 10 percent over the next year to 6,300, Goldman Sachs says
Yahoo News
few days ago at aol.com         
US ships Marburg vaccines to Rwanda after 11 die in outbreak
news
six days ago at telegraph.co.uk         
Marburg vaccines rushed to Rwanda to protect healthcare workers battling outbreak
news
six days ago at businesswire.com         
AHF Global HIV Response Demands Broader Lenacapavir Access
businesswire News
over a week ago at finance.yahoo.com         
Arcus and AstraZeneca enter trial collaboration for renal cancer treatment
Yahoo News
over a week ago at finance.yahoo.com         
Gilead Sciences, Inc. is Attracting Investor Attention Here is What You Should Know
Yahoo News
over a week ago at aol.com         
Gilead to donate remdesivir for emergency use against Marburg disease in Rwanda
news
a day ago at finance.yahoo.com         
Acquisition by Thornberry Nancy of 501 shares of Vertex Pharmaceuticals subject to Rule 16b-3
Yahoo News
3 days ago at benzinga.com         
Jeffrey Westphal Implements A Sell Strategy Offloads 48.29M In Vertex Stock
benzinga news
few days ago at finance.yahoo.com         
Vertex Pharmaceuticals Registers a Bigger Fall Than the Market Important Facts to Note
Yahoo News
over a week ago at gurufocus.com         
Insider Sale at Vertex Pharmaceuticals Inc EVP and Chief Legal Officer Jonathan Biller ...
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Optimizely Content Marketing Platform is Now Available on Google Cloud Marketplace
Yahoo News
over a week ago at businesswire.com         
Frazier Life Sciences Adds Over 630 Million to Evergreen Public Fund
businesswire News
over a week ago at finance.yahoo.com         
3 Tech Stocks With Extensive AI Applications to Hold Tight for Now
Yahoo News
over a week ago at channelnewsasia.com         
Joseph Schooling starts new career in venture capital after retiring from swimming
news
over a week ago at businesswire.com         
Elasticsearch Open Inference API and Playground Support Google Clouds Vertex AI Platform
businesswire News
over a week ago at cryptotimes.io         
Bitcoin Price Surges to 65K Ahead of 5.8B Options Expiry
news
over a week ago at news.google.com         
Viracta Therapeutics SWOT analysis narrowed focus shapes stock outlook - Investing.com
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 9034 shares by Pomerantz Roger of Viracta Therapeutics subject to Rule 16b-3
Macroaxis News
over a month ago at finance.yahoo.com         
Thornburg Names Heads of Equities and Fixed Income
Yahoo News
over a month ago at investorplace.com         
VIRX Stock Earnings Viracta Therapeutics Beats EPS for Q2 2024
sbwire news
over a month ago at seekingalpha.com         
Viracta stock jumps after corporate update
seekingalpha News
over a month ago at globenewswire.com         
Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Macroaxis News: globenewswire.com
over two months ago at news.google.com         
VIRX stock touches 52-week low at 0.43 amid market challenges - Investing.com
Google News at Macroaxis
over two months ago at news.google.com         
Viracta Therapeutics Trading Down 1.1 percent - Defense World
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Pomerantz Roger of 9034 shares of Viracta Therapeutics subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
Viracta Therapeutics Announces New Employment Inducement Grant - Quantisnow
Google News at Macroaxis
2 days ago at finance.yahoo.com         
Can United Therapeutics Corporation Capitalize on Record Revenue to Drive Future Growth?
Yahoo News
3 days ago at investing.com         
United Therapeutics CFO trades over 2.5m in stock
Investing News at Macroaxis
few days ago at seekingalpha.com         
Liquidia jumps as court rejects United Therapeutics request for appeal in patent dispute
seekingalpha News
over a week ago at finance.yahoo.com         
Global Inhalable Drugs Market to Register Incremental Growth at a CAGR of 6 percent by 2030 DelveIns...
Yahoo News
over a week ago at finance.yahoo.com         
Martine Rothblatt to Keynote Speaker at eMerge Americas 2025
Yahoo News
over a week ago at electrek.co         
Disposition of 817 shares by James Edgemond of United Therapeutics at 120.26 subject to Rule 16b-3
news
over a week ago at aol.com         
Manchester gets offer from United Therapeutics to buy nearly 350 acres in Hacket Hill area
news
over two weeks ago at talkmarkets.com         
Thai Stock Amata Corporation
news
over two weeks ago at benzinga.com         
Heres How Much 1000 Invested In United Therapeutics 5 Years Ago Would Be Worth Today
benzinga news
over two weeks ago at insidermonkey.com         
United Therapeutics Is Thriving on Strong Demand and Smart Pricing
insidermonkey News
a minute ago at finance.yahoo.com         
Genethon Pursues Different Strategies for Ensuring Patient Access to Gene Therapies for Rare Disease...
Yahoo News
3 days ago at gurufocus.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over a week ago at benzinga.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
benzinga news
over a week ago at finance.yahoo.com         
Is Sarepta Therapeutics, Inc. One of the Best Revenue Growth Stocks to Buy According to Analysts?
Yahoo News
over a week ago at businesswire.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
businesswire News
over a week ago at statnews.com         
Why are Genentech cancer researchers worried?
news
over two weeks ago at gurufocus.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
Metsera touts long-acting GLP-1 drug Novartis strikes an AI deal
Yahoo News
over two weeks ago at thelincolnianonline.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
news
a day ago at finance.yahoo.com         
Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Appears Robust With 90 Key P...
Yahoo News
3 days ago at finance.yahoo.com         
Asthma Capitals Report Drives Policy Change Agenda
Yahoo News
few days ago at seekingalpha.com         
Regeneron sees IPRD impact of about 0.43share on Q3 income
seekingalpha News
few days ago at seekingalpha.com         
Regeneron co-founder warns of harms from weight-loss drugs FT
seekingalpha News
few days ago at insidermonkey.com         
Regeneron Pharmaceuticals, Inc. A Buzzing AI Health Stock to Add to Your Portfolio
insidermonkey News
six days ago at bizjournals.com         
Sale price for QuadGraphics plant makes deal one of the largest in update New York
bizjournals News
over a week ago at gurufocus.com         
Disposition of 900 shares by Stahl Neil of Regeneron Pharmaceuticals subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
BioNTech Highlights AI Capabilities and RD Use Cases at Inaugural AI Day
Yahoo News
over a week ago at benzinga.com         
100 Invested In This Stock 5 Years Ago Would Be Worth 400 Today
benzinga news
over a week ago at seekingalpha.com         
Novo Nordisks Ozempic, RegeneronSanofis Dupixent set to advance in top drug sales
seekingalpha News
2 days ago at zacks.com         
Strength Seen in Dianthus Therapeutics, Inc. Can Its 5.7 percent Jump Turn into More Strength?
zacks News
over two weeks ago at www.macroaxis.com         
Acquisition by Gut Robert of 17060 shares of Uniqure NV at 20.18 subject to Rule 16b-3
Macroaxis News
over three weeks ago at www.macroaxis.com         
Acquisition by Jacques Rachelle Suzanne of 8080 shares of Uniqure NV subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Acquisition by Kaye Jack of 15840 shares of Uniqure NV at 4.57 subject to Rule 16b-3
Macroaxis News
over a month ago at finance.yahoo.com         
uniQure Announces Dosing of First Patient in Phase IIIa Clinical Trialof AMT-191 for the Treatment o...
Yahoo News
over two months ago at seekingalpha.com         
uniQure GAAP EPS of -1.16, revenue of 11.1M
seekingalpha News
over two months ago at zacks.com         
UniQure Reports Q2 Loss, Tops Revenue Estimates
zacks News
over two months ago at zacks.com         
Wall Street Analysts See a 125.9 percent Upside in uniQure Can the Stock Really Move This High?
zacks News
over two months ago at finance.yahoo.com         
uniQure Announces Closing of Sale of Manufacturing Facility to Genezen
Yahoo News
over three months ago at zacks.com         
Biotech Stock Roundup KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure
zacks News
over a year ago at news.google.com         
Nivolumab Plus Relatlimab Induces Durable Responses in ... - OncLive
Google News at Macroaxis
a minute ago at finance.yahoo.com         
Merck and GTRI to develop gene therapy for Parkinsons disease
Yahoo News
2 days ago at zacks.com         
Merck Outpaces Stock Market Gains What You Should Know
zacks News
3 days ago at cnbc.com         
Cramers Lightning Round I like Target right here
cnbc News
few days ago at businesswire.com         
Kinaxis refora as operaes da cadeia de suprimentos da Ono Pharmaceutical
businesswire News
few days ago at insidermonkey.com         
Merck Co Inc. Analysts Are Bullish On This Quality Stock Right Now
insidermonkey News
few days ago at fool.com         
Is Summit Therapeutics a Millionaire Maker?
fool News
six days ago at accesswire.com         
Career on Purpose Mercks Skills-First Program
news
six days ago at washingtonexaminer.com         
Who has and hasnt endorsed Harris and Trump this election cycle?
news
over a week ago at fxstreet.com         
Merck stock edges lower as CMS alters negotiating process
Fxstreet News at Macroaxis
over a week ago at finance.yahoo.com         
Merck Dips More Than Broader Market What You Should Know
Yahoo News
a minute ago at simplywall.st         
Jazz Pharmaceuticals investors are sitting on a loss of 20 percent if they invested a year ago
Simply Wall St News at Macroaxis
2 days ago at insidermonkey.com         
Jazz Pharmaceuticals plc Among The Stocks With Biggest Upside Potential According to Hedge Funds
insidermonkey News
3 days ago at 48hills.org         
Live Shots Gavin Tureks disco joy caught the light at Brick Mortar
news
over a week ago at finance.yahoo.com         
Is Jazz Pharmaceuticals Stock Undervalued Right Now?
Yahoo News
over a week ago at kalkinemedia.com         
Employee Engagement at Jazz Pharmaceuticals Cultivating Our Unique Culture
news
over two weeks ago at simplywall.st         
Jazz Pharmaceuticals plc Looks Inexpensive But Perhaps Not Attractive Enough
Simply Wall St News at Macroaxis
over two weeks ago at businesswire.com         
SUNOSI for Obstructive Sleep Apnea Market Research 2024 Size, Regulatory Milestones, Patents, Sales ...
businesswire News
over three weeks ago at finance.yahoo.com         
Jazz Pharmaceuticals earnings have declined over five years, contributing to shareholders 16 percent...
Yahoo News
over three weeks ago at finance.yahoo.com         
Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in H...
Yahoo News
over three weeks ago at 48hills.org         
You deserve to have a good life Animal Prince brings radical retro-pop joy
news
a day ago at benzinga.com         
A Look Into Incyte Incs Price Over Earnings
benzinga news
3 days ago at finance.yahoo.com         
GMAB or INCY Which Is the Better Value Stock Right Now?
Yahoo News
over a week ago at businesswire.com         
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635
businesswire News
over a week ago at investors.com         
Disposition of 2136 shares by Sheila Denton of Incyte at 67.63 subject to Rule 16b-3
Investors Business Daily at Macroaxis
over a week ago at finance.yahoo.com         
THE NATIONAL ECZEMA ASSOCIATIONS ANNUAL ECZEMA AWARENESS MONTH IN OCTOBER HIGHLIGHTS THE LIVED EXPER...
Yahoo News
over two weeks ago at businesswire.com         
Plusieurs prsentations de donnes de dernire minute drives du portefeuille dermatologique dIncyte von...
businesswire News
over two weeks ago at businesswire.com         
Plusieurs prsentations de donnes de dernire minute drives du portefeuille dermatologique dIncyte von...
businesswire News
over two weeks ago at businesswire.com         
Resumen En el European Academy of Dermatology and Venereology 2024 se presentarn varios datos de lti...
businesswire News
over two weeks ago at businesswire.com         
Riassunto Il Congresso 2024 della European Academy of Dermatology and Venereology comprender una ser...
businesswire News
over two weeks ago at kalkinemedia.com         
Innovent Announces NMPA Acceptance of NDA for Picankibart for Treating Moderate to Severe Plaque Pso...
news
few days ago at news.google.com         
Dimensional Fund Advisors LP Reduces Stake in Immunovant, Inc. - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Immunovant Stock Rating Reaffirmed by HC Wainwright - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
Goldman Sachs sustains price target, buy rating on Immunovant shares - Investing.com
Google News at Macroaxis
over three weeks ago at zacks.com         
Biotech Stock Roundup TERN, SMMT Stocks Surge on Study Data, GSKs Vaccine Study Fails More
zacks News
over a month ago at globenewswire.com         
Immunovant Provides Update on Graves Disease Development Program
Macroaxis News: globenewswire.com
over a month ago at finance.yahoo.com         
Whats Going In With Vivek Ramaswamy-Founded Roivant Sciences Stock On Monday?
Yahoo News
over a month ago at zacks.com         
Why Is Immunovant Up 13.8 percent Since Last Earnings Report?
zacks News
over a month ago at news.google.com         
Short Interest in Immunovant, Inc. Grows By 9.1 percent - MarketBeat
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 598 shares by Salzmann Peter of Immunovant at 32.32 subject to Rule 16b-3
Macroaxis News
over two months ago at finance.yahoo.com         
Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2...
Yahoo News
over a year ago at www.macroaxis.com         
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop add...
Google News at Macroaxis
over a year ago at businesswire.com         
Horizon Therapeutics plc Rule 2.12 Announcement
businesswire News
over a year ago at benzinga.com         
Heres How Much 1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today
benzinga news
over a year ago at news.google.com         
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
news
over a year ago at finance.yahoo.com         
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
Yahoo News
over a year ago at finance.yahoo.com         
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocac...
Yahoo News
over a year ago at marketwatch.com         
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are th...
marketwatch News
over a year ago at thelincolnianonline.com         
Horizon Therapeutics Public Issues Earnings Results
news
over a month ago at zacks.com         
Biotech Stock Roundup REGNs Drug Approval, LXRX, RYTM Stocks Gain on Update More
zacks News
over a month ago at zacks.com         
Galapagos Up on FDA Nod to Begin Phase III Lymphoma Study
zacks News
over a month ago at benzinga.com         
Galapagos receives transparency notification from FMR LLC
benzinga news
over two months ago at gurufocus.com         
Galapagos NV Earnings Call Transcript Highlights Strong Cash Position and ...
Gurufocus Stories at Macroaxis
over two months ago at benzinga.com         
FDA Approves Adaptimmune Therapeutics Engineered Cell Therapy As First For Solid Tumor And New Thera...
benzinga news
over two months ago at news.google.com         
Belgium stocks lower at close of trade BEL 20 down 0.90 percent - Investing.com
Google News at Macroaxis
over three months ago at benzinga.com         
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at...
benzinga news
over three months ago at seekingalpha.com         
Adaptimmune, Galapagos to collaborate on uza-cel T-cell therapy
seekingalpha News
over three months ago at finance.yahoo.com         
Galapagos NV Q1 2024 Earnings Call Transcript
Yahoo News
over three months ago at seekingalpha.com         
Galapagos reports Q1 results
seekingalpha News
2 days ago at zacks.com         
ACAD or TECH Which Is the Better Value Stock Right Now?
zacks News
3 days ago at businesswire.com         
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
few days ago at benzinga.com         
AstraZeneca Inks 1.92B License Pact With Hong Kong-Based Firm To Boost Cardiovascular Pipeline
benzinga news
over a week ago at news.google.com         
Millennium Management LLC Has 47.74 Million Stake in ACADIA Pharmaceuticals Inc. - MarketBeat
Google News at Macroaxis
over two weeks ago at businesswire.com         
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
over two weeks ago at kalkinemedia.com         
Acadia Pharmaceuticals Inc. Welcomes New CEO Catherine Owen Adams
news
over two weeks ago at seekingalpha.com         
Insider Trading
seekingalpha News
over a month ago at businesswire.com         
ACADIA HEALTHCARE INVESTOR ALERT ScottScott Attorneys at Law LLP Investigates Marathon Petroleum Cor...
businesswire News
over a month ago at zacks.com         
Implied Volatility Surging for ACADIA Pharmaceuticals Stock Options
zacks News
over a month ago at benzinga.com         
Mark Schneyer Implements A Sell Strategy Offloads 148K In ACADIA Pharmaceuticals Stock
benzinga news
2 days ago at finance.yahoo.com         
ONCOLOGY COMMERCIALIZATION LEADER P.J. HALEY TO JOIN NETRAMARK BOARD OF DIRECTORS
Yahoo News
3 days ago at simplywall.st         
With 72 percent institutional ownership, Exelixis, Inc. is a favorite amongst the big guns
Simply Wall St News at Macroaxis
few days ago at thelincolnianonline.com         
Royal Bank of Canada Increases Exelixis Price Target to 30.00
news
over a week ago at benzinga.com         
Disposition of 16298 shares by Michael Morrissey of Exelixis subject to Rule 16b-3
benzinga news
over a week ago at zacks.com         
Disposition of 100000 shares by Haley Patrick J. of Exelixis at 24.41 subject to Rule 16b-3
zacks News
over a week ago at zacks.com         
EXEL vs. CSLLY Which Stock Is the Better Value Option?
zacks News
over a week ago at news.google.com         
AQR Capital Management LLC Buys 370,199 Shares of Exelixis, Inc. - MarketBeat
Google News at Macroaxis
over two weeks ago at investing.com         
Exelixis EVP Jeffrey Hessekiel sells shares worth over 659k
Investing News at Macroaxis
over two weeks ago at www.macroaxis.com         
Disposition of 25000 shares by Hessekiel Jeffrey of Exelixis at 26.38 subject to Rule 16b-3
Macroaxis News
over two weeks ago at bizjournals.com         
Finalist, Public Company, Medium Christopher J. Senner, Exelixis Inc.
bizjournals News
over a year ago at gurufocus.com         
Top 5 4th Quarter Trades of BP PLC
Gurufocus Stories at Macroaxis
2 days ago at gurufocus.com         
Collegium Pharmaceutical Inc Q2 2024 Earnings Call Highlights Strong Revenue Growth and ...
Gurufocus Stories at Macroaxis
six days ago at gurufocus.com         
Collegium Pharmaceutical Inc Stock Price Up 2.78 percent on Oct 4
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
Should We Be Delighted With Collegium Pharmaceutical, Inc.s ROE Of 46?
Yahoo News
over two weeks ago at news.google.com         
Collegium Pharmaceutical, Inc. Shares Bought by Rubric Capital Management LP - MarketBeat
Google News at Macroaxis
over three weeks ago at benzinga.com         
Collegium Pharmaceutical Insider Trades Send A Signal
benzinga news
over three weeks ago at finance.yahoo.com         
Are Medical Stocks Lagging Context Therapeutics Inc. This Year?
Yahoo News
over a month ago at finance.yahoo.com         
Should Value Investors Buy Collegium Pharmaceutical Stock?
Yahoo News
over a month ago at gurufocus.com         
Insider Sale EVP and General Counsel Shirley Kuhlmann Sells 20,225 Shares of Collegium ...
Gurufocus Stories at Macroaxis
over a month ago at globenewswire.com         
Collegium Completes Acquisition of Ironshore Therapeutics
Macroaxis News: globenewswire.com
over a month ago at simplywall.st         
Should We Be Delighted With Collegium Pharmaceutical, Inc.s ROE Of 46?
Simply Wall St News at Macroaxis
2 days ago at finance.yahoo.com         
Analysts Rate Cogent Biosciences, Inc. as Moderate Buy with 15 Target
Yahoo News
over a week ago at thelincolnianonline.com         
Citigroup Increases Cogent Biosciences Price Target to 15.00
news
over a month ago at finance.yahoo.com         
Cogent Biosciences, Inc. This Small-Cap Healthcare Stock Is A Good Buy Right Now
Yahoo News
over a month ago at news.google.com         
Hennion Walsh Asset Management Inc. Invests 1.08 Million in Cogent Biosciences, Inc. - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Cogent Biosciences Trading 10.1 percent Higher - MarketBeat
Google News at Macroaxis
over two months ago at finance.yahoo.com         
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
Yahoo News
over two months ago at news.google.com         
Trading Report - Stock Traders Daily
Google News at Macroaxis
over two months ago at news.google.com         
Where are the Opportunities in - Stock Traders Daily
Google News at Macroaxis
over three months ago at news.google.com         
Trading Report - Stock Traders Daily
Google News at Macroaxis
over three months ago at zacks.com         
Cogent Up on SUMMIT Study Update Post Positive FDA Meeting
zacks News
2 days ago at gurufocus.com         
Coherus BioSciences Inc Q2 2024 Earnings Call Highlights Strong Revenue Growth and ...
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
Short Interest Surges to 21.83 percent as Coherus BioSciences, Inc. Faces Revenue Challenges
Yahoo News
over two weeks ago at finance.yahoo.com         
Institutional owners may take dramatic actions as Coherus BioSciences, Inc.s recent 12 percent drop ...
Yahoo News
over a month ago at www.macroaxis.com         
Acquisition by Newcomer Lee Nisley of 54000 shares of Coherus BioSciences at 12.44 subject to Rule 1...
Macroaxis News
over a month ago at news.google.com         
UBS Downgrades Coherus BioSciences - MSN
Google News at Macroaxis
over two months ago at finance.yahoo.com         
Coherus BioSciences Second Quarter 2024 Earnings Beats Expectations
Yahoo News
over two months ago at zacks.com         
Coherus BioSciences Reports Q2 Loss, Tops Revenue Estimates
zacks News
over two months ago at seekingalpha.com         
Acquisition by Bryan Mcmichael of 75000 shares of Coherus BioSciences at 1.24 subject to Rule 16b-3
seekingalpha News
over two months ago at www.macroaxis.com         
Acquisition by Paul Reider of 40000 shares of Coherus BioSciences at 2.41 subject to Rule 16b-3
Macroaxis News
over three months ago at simplywall.st         
Coherus BioSciences, Inc.s latest 12 percent decline adds to one-year losses, institutional investor...
Simply Wall St News at Macroaxis
few days ago at simplywall.st         
Insiders At Blueprint Medicines Sold US7.4m In Stock, Alluding To Potential Weakness
Simply Wall St News at Macroaxis
six days ago at investing.com         
Blueprint Medicines executive sells over 324k in stock
Investing News at Macroaxis
over a week ago at news.google.com         
Wall Street SWOT Blueprint Medicines stock rides Ayvakit wave amid pipeline promise - Investing.com
Google News at Macroaxis
over two weeks ago at news.google.com         
Edgestream Partners L.P. Invests 1.11 Million in Blueprint Medicines Co. - MarketBeat
Google News at Macroaxis
over three weeks ago at finance.yahoo.com         
Strength Seen in Denali Therapeutics Can Its 10.1 percent Jump Turn into More Strength?
Yahoo News
over a month ago at accesswire.com         
Blueprint Medicines Corporation Is Being Investigated For Securities Fraud And Stakeholders With Los...
news
over a month ago at simplywall.st         
Even though Blueprint Medicines has lost US577m market cap in last 7 days, shareholders are still up...
Simply Wall St News at Macroaxis
over a month ago at accesswire.com         
Blueprint Medicines Corporation May Have Defrauded Shareholders And The Schall Law Firm Wants Those ...
news
over a month ago at accesswire.com         
Disposition of 4409 shares by Michael Landsittel of Blueprint Medicines at 95.23 subject to Rule 16b...
news
over a month ago at accesswire.com         
Shareholders Can Now Join The Schall Law Firm In Investigating Securities Related Infractions By Blu...
news
a day ago at seekingalpha.com         
BioMarin resumed at Raymond James at outperform as stock price has hit floor
seekingalpha News
3 days ago at benzinga.com         
3 Oversold Stocks with Big RSI Rebound Potential
benzinga news
six days ago at zacks.com         
Do Options Traders Know Something About BioMarin Stock We Dont?
zacks News
over a week ago at bizjournals.com         
Petri Dish IPO-bound drugmaker strikes BioMarin deal, plus other biotech news
bizjournals News
over a week ago at finance.yahoo.com         
Down -22.94 percent in 4 Weeks, Heres Why You Should You Buy the Dip in BioMarin
Yahoo News
over a week ago at finance.yahoo.com         
BMRN or MYGN Which Is the Better Value Stock Right Now?
Yahoo News
over a week ago at zacks.com         
Why BioMarin Pharmaceutical is a Top Growth Stock for the Long-Term
zacks News
over a week ago at gurufocus.com         
Insider Trading
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
BioMarin Pharmaceutical Updates FY 2024 Earnings Guidance
news
over two weeks ago at benzinga.com         
Biomarin Pharmaceutical Options Trading A Deep Dive into Market Sentiment
benzinga news
a day ago at seekingalpha.com         
7 children given bluebirds Skysona developed blood cancer study
seekingalpha News
3 days ago at gurufocus.com         
Bluebird Bio Stock Dips Amid Market Volatility
Gurufocus Stories at Macroaxis
six days ago at businesswire.com         
bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
over a week ago at investing.com         
Bluebird Bio CEO sells shares worth over 18k
Investing News at Macroaxis
over a week ago at prnewswire.com         
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS ENCOURAGES MEMBERS TO DISCUSS COLORECTAL CANCER SCREENING WI...
prnewswire News
over a week ago at thelincolnianonline.com         
bluebird bio Coverage Initiated at StockNews.com
news
over a week ago at thelincolnianonline.com         
bluebird bio Price Target Lowered to 2.00 at Wells Fargo Company
news
over two weeks ago at prnewswire.com         
3,000 BLUE CROSS BLUE SHIELD OF MASSACHUSETTS EMPLOYEES VOLUNTEER IN LOCAL COMMUNITIES TO CELEBRATE ...
prnewswire News
over two weeks ago at bizjournals.com         
bluebird bio to undergo more layoffs
bizjournals News
over two weeks ago at finance.yahoo.com         
Gene Therapy-Focused Bluebird Bio Restructures, Cuts Is Workforce By 25, Seeks To Breakeven Next Yea...
Yahoo News
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
2 days ago at medcitynews.com         
Scholar Rock Scores 300M for Regulatory Filings Launch Plans for Neuromuscular Disease Drug
news
3 days ago at bizjournals.com         
Sage halts another drug trial, this time in Alzheimers disease
bizjournals News
few days ago at zacks.com         
Why Biogen Inc. is a Top Value Stock for the Long-Term
zacks News
six days ago at finance.yahoo.com         
Top Companies, Marketers, CEOs, Products, and Initiatives Were Celebrated During Trailblazer Gala on...
Yahoo News
over a week ago at finance.yahoo.com         
Biogen Inc. Among the Best Bargain Stocks to Buy In October
Yahoo News
over a week ago at finance.yahoo.com         
Investors in Biogen have unfortunately lost 32 percent over the last three years
Yahoo News
over a week ago at newswire.com         
Living Security Announces AI-Powered Cybersecurity Recommendations
news
over a week ago at finance.yahoo.com         
Multiple Sclerosis Therapeutic Market to hit USD 38.1 billion by 2032, says Global Market Insights I...
Yahoo News
over a week ago at cnbc.com         
The one sector of the stock market that is cheap with upside today
cnbc News
over a year ago at finance.yahoo.com         
Orphan Drug Market Size Share to Surpass 3199.3 Billion by 2028 Vantage Market Research
Yahoo News
over a week ago at thelincolnianonline.com         
JMP Securities Reaffirms Market Outperform Rating for Allakos
news
over three weeks ago at news.google.com         
Allakos stock plunges to 52-week low of 0.56 amid market challenges - Investing.com
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 13665 shares by Radford Harlan Baird of Allakos at 0.65 subject to Rule 16b-3
Macroaxis News
over a month ago at news.google.com         
Vanguard Group Inc. Raises Stock Holdings in Allakos Inc. - Defense World
Google News at Macroaxis
over two months ago at news.google.com         
Allakos stock plunges to 52-week low of 0.67 amid steep annual decline - Investing.com
Google News at Macroaxis
over two months ago at finance.yahoo.com         
Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results
Yahoo News
over two months ago at finance.yahoo.com         
Can Allakos Afford To Invest In Growth?
Yahoo News
over three months ago at simplywall.st         
Insiders Sold Allakos At US1.01, Meanwhile Stock Sits Near US0.76
Simply Wall St News at Macroaxis
over three months ago at accesswire.com         
The Schall Law Firm Initiates Investigation Into Allegations Against Allakos Inc And Encourages Impa...
news
over three months ago at accesswire.com         
The Schall Law Firm Initiates Investigation Into Allegations Against Allakos Inc And Encourages Impa...
news
over a year ago at news.google.com         
Current and Future Analysis of Rho Kinases Inhibitor Market With New Business Strategies and Forecas...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Alphacentric Lifesci that are available to investors today. That information is available publicly through Alphacentric media outlets and privately through word of mouth or via Alphacentric internal channels. However, regardless of the origin, that massive amount of Alphacentric data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Alphacentric Lifesci news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Alphacentric Lifesci relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Alphacentric Lifesci's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Alphacentric Lifesci alpha.

Other Information on Investing in Alphacentric Mutual Fund

Alphacentric Lifesci financial ratios help investors to determine whether Alphacentric Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alphacentric with respect to the benefits of owning Alphacentric Lifesci security.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stocks Directory
Find actively traded stocks across global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments